NCT01292213终止不适用
Identification and Characterisation of Bacteria Causing Chronic Cough Among Children in the United Kingdom
适应症
试验速览
- 阶段
- 不适用
- 状态
- 终止
- 入组人数
- 19
- 试验地点
- 1
- 主要终点
- Occurrence of Haemophilus influenzae, in the absence of co-infection with other bacteria, in the lower airways of cases and controls
研究概览
简要总结
The purpose of this study is to investigate the role of Haemophilus influenzae and other bacteria in causing chronic cough, through a direct comparison of chronic cough cases and healthy controls recruited from paediatric respiratory clinics in the United Kingdom.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Control
- 时间视角
- Prospective
入排标准
- 年龄范围
- 6 Months 至 72 Months（Child）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Subjects who the investigator believes that parent(s)/ legally acceptable representative can and will comply with the requirements of the protocol.
- •A male or female child between, and including, six to 72 months of age at the time of enrolment.
- •Written informed consent obtained from the parent(s)/ legally acceptable representative of the subject.
- •No antibiotic therapy within four weeks prior to the visit.
- •No cystic fibrosis or known major immunodeficiency such as agammaglobulinaemia, T cell deficiency or Human Immunodeficiency Virus / Acquired Immune Deficiency Syndrome.
- •No documented evidence or suspicion of gastroesophageal reflux disease.
- •No evidence of an upper viral respiratory infection four weeks prior to the visit.
- •In addition, all subjects regarded as 'cases' must satisfy all the following criteria at study entry:
- •Persistent cough greater than eight weeks.
- •No response to five-day prednisolone treatment.
- •Chest X-ray showing no evidence of a lobar pneumonia or gross structural abnormality.
- •In addition, all subjects regarded as 'controls' must satisfy the following criteria at study entry:
- •No respiratory symptoms four weeks prior to the visit.
- •No documented evidence or suspicion of lung disease upon physical examination.
排除标准
- •Concurrently participating in another study, at any time during the study period, in which the subject has been or will be exposed to an investigational or a non-investigational product.
- •Use of any investigational or non-registered product within 30 days prior to study procedures, or planned use during the study period.
- •Any confirmed or suspected immunosuppressive or immunodeficient condition, based on medical history and physical examination.
- •Child in care.
结局指标
主要结局
Occurrence of Haemophilus influenzae, in the absence of co-infection with other bacteria, in the lower airways of cases and controls
时间窗: 12-15 months from study initiation
次要结局
- Bacterial load of Haemophilus influenzae in the lower airways and nasopharynx/ oropharynx of cases and controls(12-15 months from study initiation)
- Occurrence of Haemophilus influenzae in cough swabs and nasopharynx/ oropharynx of cases and controls(12-15 months from study initiation)
- Occurrence of Haemophilus influenzae in the lower airways and/or nasopharynx/ oropharynx of cases and controls(12-15 months from study initiation)
- Antimicrobial resistance of Haemophilus influenzae in lower airways(12-15 months from study initiation)
- Occurrence of Streptococcus pneumoniae in the lower airways and/or nasopharynx/ oropharynx of cases and controls(12-15 months from study initiation)
- Bacterial load of Streptococcus pneumoniae in the lower airways and nasopharynx/ oropharynx of cases and controls(12-15 months from study initiation)
- Occurrence of Haemophilus haemolyticus in the lower airways and nasopharynx/ oropharynx of cases and controls(12-15 months from study initiation)
- Occurrence of Streptococcus pneumoniae in the lower airways of cases and controls(12-15 months from study initiation)
- Occurrence of other bacterial pathogens in the lower airways of cases and controls(12-15 months from study initiation)
- Bacterial load of Moraxella catarrhalis in the lower airways and nasopharynx/ oropharynx of cases and controls(12-15 months from study initiation)
- Occurrence of serotypes of Haemophilus influenzae in the lower airways and nasopharynx/ oropharynx of cases and controls(12-15 months from study initiation)
- Occurrence of Haemophilus influenzae, regardless of co-infection with other bacteria, in the lower airways of cases and controls(12-15 months from study initiation)
- Occurrence of Moraxella catarrhalis in the lower airways of cases and controls(12-15 months from study initiation)
- Occurrence of Streptococcus pneumoniae in cough swabs and nasopharynx/ oropharynx of cases and controls(12-15 months from study initiation)
- Occurrence of other bacterial pathogens in the lower airways and/or nasopharynx/ oropharynx of cases and controls(12-15 months from study initiation)
- Antimicrobial resistance of Moraxella catarrhalis in lower airways(12-15 months from study initiation)
- Occurrence of viral pathogens in the lower airways and nasopharynx of cases and controls(12-15 months from study initiation)
- Occurrence of Moraxella catarrhalis in cough swabs and nasopharynx/ oropharynx of cases and controls(12-15 months from study initiation)
- Occurrence of serotypes of Streptococcus pneumoniae in the lower airways and nasopharynx/ oropharynx of cases and controls(12-15 months from study initiation)
- Antimicrobial resistance of Streptococcus pneumoniae in lower airways(12-15 months from study initiation)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
1 期
Nontypeable H. Influenzae in Healthy AdultsHaemophilus Influenzae (NTHI)NCT00905385National Institute of Allergy and Infectious Diseases (NIAID)15
已完成
1 期
Bacterial Composition and Immune Responses in the Nose and Oropharynx During Influenza InfectionInfluenzaNCT02597647University of California, Los Angeles17
已完成
不适用
Haemophilus Influenzae Pneumonia in AdultsHaemophilus Influenzae PneumoniaNCT06517277Assistance Publique - Hôpitaux de Paris203
已完成
不适用
Identification and Characterization of Bacteria in the Lungs of Children From 6 Months up to 6 Years Old, With Suspected Infection of the Lungs, in Spain.Infections, StreptococcalNCT02838407GlaxoSmithKline197
已完成
3 期
Phase 3 Study of A Group A, C Polysaccharide Meningococcal and Type b Haemophilus Influenzal Conjugate VaccineInfluenzaMeningitisNCT01580033Jiangsu Province Centers for Disease Control and Prevention900